Literature DB >> 6894902

Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute.

A Goldin, J M Venditti, J S Macdonald, F M Muggia, J E Henney, V T Devita.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6894902     DOI： 10.1016/0014-2964(81)90027-x

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  49 in total

1.  Desoxyepothilone B is curative against human tumor xenografts that are refractory to paclitaxel.

Authors:  T C Chou; X G Zhang; C R Harris; S D Kuduk; A Balog; K A Savin; J R Bertino; S J Danishefsky
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-22       Impact factor: 11.205

2.  Lack of cross-resistance of a doxorubicin-resistant B16 melanoma line with 4'-deoxy-4'-iodo-doxorubicin.

Authors:  R Supino; M Mariani; E Prosperi; G Parmiani
Journal:  Cancer Chemother Pharmacol       Date:  1988       Impact factor: 3.333

Review 3.  Predictive testing in cancer chemotherapy. I. In vivo.

Authors:  P H Slee; A T Van Oosterom; E A De Bruijn
Journal:  Pharm Weekbl Sci       Date:  1985-06-21

4.  A phase I study of meta-azidopyrimethamine ethanesulphonate (MZPES)--a new dihydrofolate reductase inhibitor.

Authors:  N S Stuart; S M Crawford; G R Blackledge; E S Newlands; J Slack; R Hoffman; M F Stevens
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

5.  Antitumor activity of MST-16, a novel derivative of bis(2,6-dioxopiperazine), in murine tumor models.

Authors:  T Narita; S Yaguchi; T Komatsu; M Takase; A Hoshino; M Inaba; S Tsukagoshi
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

Review 6.  Biochemical mechanisms in colon xenografts: thymidylate synthase as a target for therapy.

Authors:  P J Houghton; J A Houghton; B J Hazelton; S Radparvar
Journal:  Invest New Drugs       Date:  1989-04       Impact factor: 3.850

7.  Fluorinated anthracyclines: synthesis and biological activity.

Authors:  K C Tonkin; R T Brownlee; F Zunino; D R Phillips
Journal:  Invest New Drugs       Date:  1990-02       Impact factor: 3.850

8.  Development of new anti-cancer drugs.

Authors:  H M Pinedo
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

Review 9.  N-methyl antitumour agents. A distinct class of anticancer drugs?

Authors:  D Newell; A Gescher; S Harland; D Ross; C Rutty
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

10.  Antineoplastic activity of idazoxan hydrochloride.

Authors:  G F Eilon; L Weisenthal; M Stupecky; G Landucci; L M Slater
Journal:  Cancer Chemother Pharmacol       Date:  2009-03-24       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.